Ascentage Pharma Group International (NASDAQ:AAPG - Get Free Report) fell 4% during mid-day trading on Tuesday . The stock traded as low as $19.58 and last traded at $19.58. Approximately 708 shares were traded during trading, a decline of 99% from the average session volume of 81,598 shares. The stock had previously closed at $20.40.
Analyst Ratings Changes
Separately, JPMorgan Chase & Co. started coverage on Ascentage Pharma Group International in a report on Thursday, March 27th. They issued an "overweight" rating on the stock.
Read Our Latest Stock Report on AAPG
Ascentage Pharma Group International Stock Up 5.6 %
The firm's 50 day moving average is $19.53.
About Ascentage Pharma Group International
(
Get Free Report)
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Recommended Stories
Before you consider Ascentage Pharma Group International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ascentage Pharma Group International wasn't on the list.
While Ascentage Pharma Group International currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
